Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

A specific DNA region controls skin cell gene expression by working with certain proteins.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Hairless protein can both repress and activate vitamin D receptor functions, affecting gene regulation.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

A genetic mutation in the CDH3 gene causes hair loss and vision problems in a young Saudi girl.

Pachyonychia congenita is linked to a keratin gene on chromosome 17.

Pigmented rings with central clearing help diagnose melasma more accurately.

A new method using stamps improves symmetry in hair restoration surgery.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Retinoic acid-binding proteins in skin are regulated by β-catenin and Notch signalling.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Decorin helps hair growth by influencing specific cell signals.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

PlacMA hydrogels from human placenta are versatile and useful for cell culture and tissue engineering.

The demineralized bone matrix scaffold is better for cell attachment than the mineralized bone allograft.

Basal cell carcinoma shows keratin patterns similar to hair follicle structures.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Complex basal cell carcinomas need personalized treatment due to unique genetic mutations.

Connexin 30 is usually absent in normal skin but can appear in certain skin conditions.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.